7th June 2022 | Pharma Updates
15 other drugs, including paracetamol, may be sold without a prescription 'over the counter'
The government plans to allow the sale of 16 commonly used medicines such as paracetamol, diclofenac, nasal decongestants, and anti-allergics as over the counter (OTC) products, which can be purchased without a doctor’s prescription.
Famotidine tablets approved by US Food and Drug Administration
Famotidine tablets in the strengths of 20mg and 40mg have been approved by the US Food and Drug Administration. Since the filing process began in FY 2003-04, the Zydus group has received 315 approvals and has filed over 420 ANDAs.
MMR vaccine from GSK approved by FDA for first time in more than half a century
GSK announced that the FDA had approved its measles, mumps, and rubella vaccine for people aged 12 months and up. Prior to its release in the United States, the Priorix shot had already been licenced in over 100 other countries.
P&G Health collaborates with Lakshya & Recycle India Foundation to promote sustainable pharmacy waste segregation and management
P&G Health’s new partnership with the Lakshya and Recycle India Foundation for a sustainable pharmacy waste segregation and management project as part of its corporate social responsibility (CSR) programme ‘SEHAT’ .
J&J gives notice to terminate COVID vaccine manufacturing contract with Emergent
Johnson & Johnson announced on Monday that it had formally informed Emergent BioSolutions of its decision to terminate the contract manufacturer’s agreement to produce COVID-19 vaccine for the drugmaker.
Novartis drug combination shows promise in treatment of childhood brain cancer
In a trial, an oral drug combination developed by the Swiss pharmaceutical company Novartis showed promise in treating a subset of patients with a common childhood brain cancer.
C2i Genomics & Karkinos Healthcare teamed up to co-develop the minimal residual disease market for cancer detection in India
The collaboration allows C2i Genomics to bring innovative cancer detection technology to drive R&D, future pharma partnerships, and clinical use in India, while also supporting the company’s long-term goals of scaling pharma R&D projects globally.